Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of the Effects of Chronic Sildenafil Citrate Therapy on Exercise Tolerance and Hemodynamics in Patients With Advanced Heart Failure.

NCT00309790 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00309790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00309790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of the Effects of Chronic Sildenafil Citrate Therapy on Exercise Tolerance and Hemodynamics in Patients With Advanced Heart Failure.
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2003
Completion date
March 31, 2006
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure